132 related articles for article (PubMed ID: 24720722)
21. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
[TBL] [Abstract][Full Text] [Related]
22. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
[TBL] [Abstract][Full Text] [Related]
23. Classification of primary hepatic tumours in the dog.
van Sprundel RG; van den Ingh TS; Guscetti F; Kershaw O; Kanemoto H; van Gils HM; Rothuizen J; Roskams T; Spee B
Vet J; 2013 Sep; 197(3):596-606. PubMed ID: 24011584
[TBL] [Abstract][Full Text] [Related]
24. Three cases of adrenocortical tumors mistaken for hepatocellular carcinomas/diagnostic pitfalls and differential diagnosis.
Park WY; Seo HI; Choi KU; Kim A; Kim YK; Lee SJ; Lee CH; Huh GY; Park DY
Ann Diagn Pathol; 2017 Dec; 31():9-13. PubMed ID: 29146062
[TBL] [Abstract][Full Text] [Related]
25. [Radiological diagnosis of hepatic tumors. Part II: Identification and differential diagnosis].
Layer G; Delorme S
Radiologe; 2007 Oct; 47(10):919-31; quiz 932-3. PubMed ID: 17898982
[TBL] [Abstract][Full Text] [Related]
26. [Liver cell carcinoma--pathomorphology and differential diagnosis].
Gerharz CD
Praxis (Bern 1994); 2001 Jan; 90(1-2):3-5. PubMed ID: 11206097
[TBL] [Abstract][Full Text] [Related]
27. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma.
Kim H; Park YN
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):813-29. PubMed ID: 25260310
[TBL] [Abstract][Full Text] [Related]
28. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes.
Ito Y; Fujioka H; Matsuzaki S; Yamamoto O; Okudaira S; Azuma T; Furui J; Kanematsu T
Hepatogastroenterology; 2003; 50(49):65-8. PubMed ID: 12629992
[TBL] [Abstract][Full Text] [Related]
30. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
[TBL] [Abstract][Full Text] [Related]
31. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
32. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
[TBL] [Abstract][Full Text] [Related]
33. [Hepatocellular carcinoma--from macroscopy to molecular pathology].
Schaff Z; Kovalszky I; Lotz G; Kiss A
Orv Hetil; 2010 Jun; 151(24):982-9. PubMed ID: 20519181
[TBL] [Abstract][Full Text] [Related]
34. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
[TBL] [Abstract][Full Text] [Related]
36. [Hepatocellular adenoma - new classification and recommendations].
Aamann L; Schultz N; Fallentin E; Hamilton-Dutoit S; Vogel I; Grønbæk H
Ugeskr Laeger; 2015 Mar; 177(12):V07140397. PubMed ID: 25786843
[TBL] [Abstract][Full Text] [Related]
37. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.
Lo RC; Ng IO
Chin J Cancer Res; 2011 Dec; 23(4):245-53. PubMed ID: 23359751
[TBL] [Abstract][Full Text] [Related]
39. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
40. Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification.
Kondo F; Fukusato T; Kudo M
Oncology; 2014; 87 Suppl 1():37-49. PubMed ID: 25427732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
